Renovascular Hypertension
Renovascular hypertension is the most common type of secondary hypertension, caused by reduced renal perfusion that activates the renin-angiotensin-aldosterone system, resulting in elevated blood pressure that can be corrected by treating the underlying renal artery stenosis. 1
Definition and Prevalence
- Renovascular hypertension accounts for 0.5-5% of all hypertension cases in the general population, but its prevalence increases to approximately 25% in elderly patients with end-stage renal disease 1
- It represents a form of secondary hypertension where the kidney "takes charge" of blood pressure regulation, elevating it to force blood through the blocked renal artery 2
- The defining criterion for true renovascular hypertension is a fall in blood pressure after intervention (angioplasty, stent placement, or surgery) 1
Etiology
Renal artery stenosis (RAS) is the primary cause of renovascular hypertension, with two major pathologic entities:
Less common causes include:
Pathophysiology
The mechanism of renovascular hypertension involves:
- Reduced renal perfusion triggers juxtaglomerular cells to release renin 4
- Renin catalyzes the conversion of angiotensinogen to angiotensin I 4
- Angiotensin-converting enzyme converts angiotensin I to angiotensin II 4
- Angiotensin II causes:
- Peripheral arteriolar vasoconstriction
- Increased renal tubular reabsorption of sodium and water
- Stimulation of aldosterone release from the adrenal cortex
- Increased sympathetic tone
- Release of vasopressin 4
- These mechanisms collectively increase blood pressure through arteriolar constriction, enhanced cardiac output, and retention of sodium and water 4
Clinical Features Suggesting Renovascular Hypertension
- Abdominal bruit
- Malignant or accelerated hypertension
- Significant hypertension (diastolic pressure >110 mmHg) in a young adult (<35 years)
- New onset hypertension after age 50
- Sudden development or worsening of hypertension
- Refractory hypertension
- Deterioration of renal function in response to ACE inhibitors
- Generalized arteriosclerotic occlusive disease with hypertension 1
Diagnostic Approach
Imaging Studies for Suspected Renovascular Hypertension
For patients with normal renal function:
- Duplex Doppler ultrasound is the recommended first-line screening test (rating 9/9) 1
- MR angiography without and with IV contrast (rating 8/9) or CT angiography with IV contrast (rating 8/9) are also highly appropriate 1
For patients with decreased renal function (eGFR <30 mL/min/1.73 m²):
- Duplex Doppler ultrasound is the preferred screening test (rating 9/9) 1
- MR angiography without IV contrast is the second choice (rating 7/9) 1
Diagnostic Criteria
- Most investigators consider a 50-60% stenosis to be significant, although perfusion pressure in a large artery is generally not reduced until stenosis exceeds 70-75% 1
- Duplex Doppler ultrasound criteria:
- Peak systolic velocity (PSV) in the main renal artery >200 cm/s (sensitivity 73-91%, specificity 75-96%)
- Renal artery to aortic systolic ratio (RAR) >3.5 1
Treatment Options
Medical therapy:
Revascularization (when medical therapy is ineffective or causes severe impairment of renal function):
Important Considerations
- The goal of treatment is not only to control hypertension but also to preserve and restore renal function 6
- Bilateral renal artery disease presents a diagnostic challenge as it is difficult to quantify the effect on blood pressure of one side versus the other 1
- Fear of acute renal failure with ACE inhibitors or ARBs should not prevent their use in most patients, as this complication is rare (<5% of patients) and reversible with revascularization 2